Doudna giving Milken Global Conference talk on CRISPR

Synthego Raises $41 Million From Investors, Including a Top Biochemist

The genetic engineering start-up Synthego may have been founded by two brothers with no formal background in the field. But it has won support from investors who now include one of the scientists who helped pioneer an important gene editing technique.

Synthego said Wednesday that it had raised $41 million in a new round of financing. The round includes the participation of Jennifer A. Doudna, the biochemist who helped discover the Crispr-Cas9 gene-editing technique that made altering DNA significantly easier.

The new financing round is meant to help Synthego expand its suite of products, which currently focuses on helping scientists in their Crispr research by providing important genetic material used in the process.

But Synthego’s founders, the brothers Paul and Michael Dabrowski, initially set out four years ago with a less specific goal: to help scientists better automate their research. Neither had a particular background in the field; they were engineers who previously worked at SpaceX, the private rocket company founded by Elon Musk.




UC Berkeley



This is a unique website which will require a more modern browser to work!

Please upgrade today!